No License to Excluded Targets. Notwithstanding anything to the contrary herein, Celgene is not licensed or granted any rights by OncoMed under this License Agreement to conduct any activities with respect to Excluded Targets or with respect to any Protein Therapeutics, Diagnostic Products, Small Molecule Compounds or any other compounds to the extent directed thereto.
Appears in 1 contract
Samples: Master Research and Collaboration Agreement (OncoMed Pharmaceuticals Inc)
No License to Excluded Targets. Notwithstanding anything to the contrary herein, Celgene is not licensed or granted any rights by OncoMed under this License Agreement to conduct any activities with respect to Excluded Targets or with respect to any Protein Therapeutics, Diagnostic Products, Small Molecule Compounds or any other compounds to the extent directed thereto.
Appears in 1 contract
Samples: Master Research and Collaboration Agreement (OncoMed Pharmaceuticals Inc)
No License to Excluded Targets. Notwithstanding anything to the contrary herein, Celgene is not licensed or granted any rights by OncoMed under this License Agreement to conduct any activities with respect to Excluded Targets or with respect to any Protein Therapeutics, Diagnostic Products, Small Molecule Compounds or any other compounds to the extent directed thereto.
Appears in 1 contract
Samples: Master Research and Collaboration Agreement (OncoMed Pharmaceuticals Inc)
No License to Excluded Targets. Notwithstanding anything to the contrary herein, Celgene is not licensed or granted any rights by OncoMed under this License Co-Co Agreement to conduct any activities with respect to Excluded Targets or with respect to any Protein Therapeutics, Diagnostic Products, Small Molecule Compounds or any other compounds to the extent directed thereto.
Appears in 1 contract
Samples: Master Research and Collaboration Agreement (OncoMed Pharmaceuticals Inc)